China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)

SHE:000999 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	28,712	26,466	23,837	17,411	14,825	13,093
Other Revenue	1,151	1,151	901.47	667.99	719.33	544.28
Revenue	29,863	27,617	24,739	18,079	15,544	13,637
Revenue Growth (YoY)	15.43%	11.63%	36.84%	16.31%	13.98%	-7.82%
Cost of Revenue	14,312	13,434	11,675	8,354	6,561	5,143
Gross Profit	15,550	14,183	13,064	9,725	8,984	8,494
Selling, General & Admin	10,486	8,878	8,489	6,135	5,992	5,947
Research & Development	1,130	801.75	714.5	593.94	560.2	459.84
Other Operating Expenses	245.98	229.73	262.72	207.05	204.39	175.49
Operating Expenses	11,891	9,992	9,521	6,942	6,770	6,602
Operating Income	3,659	4,191	3,543	2,784	2,214	1,892
Interest Expense	-96.44	-80.04	-80.78	-21.23	-14.18	-5.09
Interest & Investment Income	108.1	133.9	125.1	118.11	101.08	156.22
Currency Exchange Gain (Loss)	5.48	5.48	2.5	-56.25	-12.89	-9.68
Other Non Operating Income (Expenses)	-108.43	-15.21	-17.44	-4.11	-1.11	-21.91
EBT Excluding Unusual Items	3,568	4,235	3,572	2,820	2,287	2,012
Impairment of Goodwill	-	-	-	-65.51	-44.24	-174.95
Gain (Loss) on Sale of Investments	168.36	68.2	-28.63	2.58	5.04	6.87
Gain (Loss) on Sale of Assets	10.6	31.43	0.81	2.28	0.85	-2.69
Asset Writedown	14.03	-19.67	-82.35	-34.3	-8.1	-7.95
Other Unusual Items	278.8	278.8	292.43	237.69	202.96	225.89
Pretax Income	4,040	4,594	3,754	2,963	2,444	2,059
Income Tax Expense	607.3	815.87	580.97	466.43	345.41	441.89
Earnings From Continuing Operations	3,432	3,778	3,173	2,497	2,099	1,618
Minority Interest in Earnings	-671.44	-409.85	-320.55	-48.21	-43.49	-20.04
Net Income	2,761	3,368	2,853	2,449	2,055	1,597
Net Income to Common	2,761	3,368	2,853	2,449	2,055	1,597
Net Income Growth	-19.04%	18.05%	16.50%	19.16%	28.65%	-23.89%
Shares Outstanding (Basic)	1,660	1,665	1,656	1,669	1,654	1,656
Shares Outstanding (Diluted)	1,660	1,665	1,663	1,669	1,654	1,656
Shares Change (YoY)	-0.24%	0.10%	-0.33%	0.90%	-0.15%	-0.07%
EPS (Basic)	1.66	2.02	1.72	1.47	1.24	0.96
EPS (Diluted)	1.66	2.02	1.72	1.47	1.24	0.96
EPS Growth	-18.85%	17.94%	16.89%	18.10%	28.83%	-23.83%
Free Cash Flow	3,130	3,612	3,335	2,055	1,012	1,602
Free Cash Flow Per Share	1.89	2.17	2.00	1.23	0.61	0.97
Dividend Per Share	0.696	1.015	0.887	0.592	0.505	0.296
Dividend Growth	-57.98%	14.41%	49.99%	17.26%	70.53%	16.31%
Gross Margin	52.07%	51.36%	52.81%	53.79%	57.79%	62.28%
Operating Margin	12.25%	15.17%	14.32%	15.40%	14.24%	13.87%
Profit Margin	9.25%	12.20%	11.53%	13.54%	13.22%	11.71%
Free Cash Flow Margin	10.48%	13.08%	13.48%	11.37%	6.51%	11.75%
EBITDA	4,261	4,829	4,228	3,251	2,643	2,282
EBITDA Margin	14.27%	17.48%	17.09%	17.98%	17.00%	16.73%
D&A For EBITDA	602.35	638.08	685.71	467.17	429.17	390.19
EBIT	3,659	4,191	3,543	2,784	2,214	1,892
EBIT Margin	12.25%	15.17%	14.32%	15.40%	14.24%	13.87%
Effective Tax Rate	15.03%	17.76%	15.47%	15.74%	14.13%	21.46%
Revenue as Reported	2,246	-	-	18,079	15,544	13,637
Advertising Expenses	-	754.25	660.33	543.92	578.72	446.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.